Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 2/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29398288 | 1.00 | MDM4 (0.54) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL31647183 | 0.91 | MDM2 (0.56) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL25081912 | 0.88 | MDM4 (0.49) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL14788958 | 0.87 | MDM4 (0.59) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL14432835 | 0.87 | MDM4 (0.59) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL29400770 | 0.86 | MDM4 (0.58) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL3436129 | 0.86 | MDM4 (0.58) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL1001473 | 0.86 | MDM4 (0.58) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL16310689 | 0.85 | MDM4 (0.57) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL22154133 | 0.84 | MDM4 (0.56) | MDM4TP53SLC17A5CASP3MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894630-A | Preparation method of linaclotide | 四川轻化工大学 | 2023-04-04 | — | — | CN | claimed |
| CN-115806607-A | Site-directed cyclization method of chlorotoxin polypeptide | 哈尔滨吉象隆生物技术有限公司 | 2023-03-17 | — | — | CN | claimed |
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | VESTLANDETS INNOVASJONSSELSKAP AS (NO) | 2026-04-30 | — | — | US | disclosed |
| US-12527853-B2 | Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens | VESTLANDETS INNOVASJONSSELSKAP AS (VIS) (NO) | 2026-01-20 | — | — | US | disclosed |
| CN-118005545-B | Small-molecule antibacterial peptide mimics and application thereof | 兰州大学 | 2025-02-18 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-118005545-A | Small-molecule antibacterial peptide mimics and application thereof | 兰州大学 | 2024-05-10 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| CN-115894630-A | Preparation method of linaclotide | 四川轻化工大学 | 2023-04-04 | — | — | CN | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| US-20220249644-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | VESTLANDETS INNOVASJONSSELSKAP AS (VIS) (NO) | 2022-08-11 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | SCN8A, SCN9A, VIP | MDM4 4004/4885TP53 571/4885SLC17A5 1474/4885 |
| US-12527853-B2 | Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens | VIP, MLEC, SEC16A | MDM4 2800/4885TP53 1413/4885SLC17A5 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.